Shared on 30 Apr 25
Fair value Increased 4.78%Technology And Life Sciences Expansion Will Drive Future Value
Shared on 23 Apr 25
Fair value Decreased 1.07%A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 2.06%A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 1.51%A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 11 Mar 25
Fair value Increased 2.88%A Boost In M&A And Capital Markets Activity Will Drive Portfolio Expansion
AnalystConsensusTarget has increased revenue growth from 3.9% to 6.4% and increased future PE multiple from 13.3x to 16.5x.